The Guardian write, Drug giant GlaxoSmithKline pledges cheap medicine for world’s poor
The world’s second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.
In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents.
My hat’s off to you, Mr. Witty. This is a great step and I thank you. One more thing, though: what about the poor people right here in the US and the UK and the other “developed” countries? Will we soon live in a world where high quality medical care is more affordable in Africa than in America?
